EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

E-cadherin–driven adherens junction reinforcement promotes spheroid-mediated invasion and progression in ALK–rearranged lung cancer chemoresistance

Dawon Hong, Hyun Jung Kwon, Jiwon Jeong, Seokhyun Yoon, Jin-Haeng Chung, Sunjoo Jeong

Molecules and Cells · 2026

DOI: 10.1016/j.mocell.2026.100329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules and Cells, 2026. Verfasst von Dawon Hong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of RNA Cell Biology, Department of Bioconvergence Engineering, Dankook University Graduate School, Yongin-si 16892, Republic of Korea. Hauptthemen laut MEDLINE: Cadherins, Lung Neoplasms, Drug Resistance, Neoplasm, Anaplastic Lymphoma Kinase. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Seoul National University Bundang Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastasis of cancer cells is driven by morphogenic changes that involve cytoskeletal remodeling and adherens junction reorganization. These cytoskeletal dynamics enable cancer cells to modulate their shape, adhesion, and motility, contributing to invasion, metastasis, and therapeutic resistance. In non-small cell lung cancer, anaplastic lymphoma kinase (ALK) gene rearrangements represent key oncogenic drivers, and ALK tyrosine kinase inhibitors such as crizotinib have significantly improved clinical outcomes. However, resistance frequently develops, often through on-target mutations or poorly understood bypass mechanisms. To investigate resistance-associated morphogenic adaptation, we employed two-dimensional and three-dimensional culture systems using crizotinib-resistant H2228 cells, along with transcriptomic profiling. The resistant cells formed compact, highly organized spheroids with upregulated E-cadherin expression and reinforced adherens junctions. This was accompanied by pronounced cytoskeleton-associated remodeling, characterized by enrichment of gene sets related to ruffle assembly, tissue morphogenesis, and the positive regulation of cell motility. Knockdown of E-cadherin disrupted spheroid architecture and partially restored crizotinib sensitivity, supporting its functional role in resistance. EpCAM was notably upregulated in peripheral protrusive cells and contributed to spheroid invasiveness in the resistant phenotype. Importantly, longitudinal biopsy samples from ALK-rearranged non-small cell lung cancer patients with cancer progression revealed elevated expression of E-cadherin and EpCAM during chemotherapy. It indicates the clinical relevance of adhesion-mediated morphogenic program impacting chemoresistance. Our findings suggest that bypass resistance is mediated, in part, by cytoskeleton-associated morphogenic plasticity that promotes spheroid formation, cell-cell adhesion, and invasive behavior. Targeting cytoskeletal remodeling and adherens junction dynamics may provide a novel therapeutic approach to overcome drug resistance in metastatic ALK-rearranged lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CadherinsLung NeoplasmsDrug Resistance, NeoplasmAnaplastic Lymphoma KinaseAdherens JunctionsSpheroids, CellularCarcinoma, Non-Small-Cell LungAntigens, CDHumansCell Line, TumorNeoplasm InvasivenessCrizotinibGene RearrangementGene Expression Regulation, NeoplasticCell MovementDisease Progression

Stichwörter der Autor:innen

Anaplastic lymphoma kinase fusionE-cadherinLung adenocarcinomaResistanceSpheroid

Substanzen

CadherinsAnaplastic Lymphoma KinaseALK protein, humanCrizotinibAntigens, CD

Autor:innen und Institutionen

  • Laboratory of RNA Cell Biology, Department of Bioconvergence Engineering, Dankook University Graduate School, Yongin-si 16892, Republic of Korea.
  • Department of Pathology and Translational Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Department of Electronics & Electrical Engineering, College of Engineering, Dankook University, Yongin 16890, Republic of Korea; MLBI Lab Co Ltd, Yongin 16890, Republic of Korea.
  • Department of Pathology and Translational Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Kor…
  • Laboratory of RNA Cell Biology, Department of Bioconvergence Engineering, Dankook University Graduate School, Yongin-si 16892, Republic of Korea. Electronic address: sjsj@dankook.ac.kr.

Förderung

  • National Research Foundation of Korea
  • Seoul National University Bundang Hospital

Zitieren

APA

Hong, D., Kwon, H. J., Jeong, J., Yoon, S., Chung, J. H., & Jeong, S. (2026). E-cadherin–driven adherens junction reinforcement promotes spheroid-mediated invasion and progression in ALK–rearranged lung cancer chemoresistance. Molecules and Cells. https://doi.org/10.1016/j.mocell.2026.100329

Vancouver

Hong D, Kwon HJ, Jeong J, Yoon S, Chung JH, Jeong S. E-cadherin–driven adherens junction reinforcement promotes spheroid-mediated invasion and progression in ALK–rearranged lung cancer chemoresistance. Molecules and Cells. 2026. doi:10.1016/j.mocell.2026.100329

BibTeX
@article{Hong2026,
  author = {Hong, Dawon and Kwon, Hyun Jung and Jeong, Jiwon and Yoon, Seokhyun and Chung, Jin-Haeng and Jeong, Sunjoo},
  title = {E-cadherin–driven adherens junction reinforcement promotes spheroid-mediated invasion and progression in ALK–rearranged lung cancer chemoresistance},
  journal = {Molecules and Cells},
  year = {2026},
  doi = {10.1016/j.mocell.2026.100329}
}
Kostenlos starten →